Trastuzumab Combined With Pyrotinib and Chemotherapy for Locally Advanced, Inflammatory, or Early HER2-positive Mammary glandsCancer: One Arm, Open, Phase II Clinical Study
Latest Information Update: 05 Aug 2022
At a glance
- Drugs Pertuzumab (Primary) ; Pyrotinib (Primary) ; Trastuzumab (Primary)
- Indications Adenocarcinoma; Advanced breast cancer; Carcinoma; Early breast cancer; HER2 positive breast cancer; Inflammatory breast cancer
- Focus Therapeutic Use
- 27 Jul 2020 New trial record